Why do bodybuilders stack BPC-157 with TB-500 in the Wolverine protocol?

The stack is popular because BPC-157 and TB-500 target injury repair through completely different pathways. BPC-157 stimulates local angiogenesis and fibroblast activity via VEGF upregulation, while TB-500 drives systemic actin polymerisation and cell migration. Combining them addresses both vascular rebuilding and cellular repopulation simultaneously — a dual-axis approach neither peptide can replicate on its own.

What does a typical Wolverine Stack weekly protocol look like?

A common research-based template runs BPC-157 at 250–500 mcg once daily (subcutaneous or intramuscular, site-adjacent), paired with TB-500 at 2–2.5 mg twice weekly for the first four weeks, then dropping to a maintenance dose of 2 mg once weekly. The acute phase targets active injury; the maintenance phase supports ongoing collagen remodelling. Always reconstitute each peptide separately in bacteriostatic water.

Which injury types benefit most from running BPC-157 alongside TB-500?

Ligament and tendon tears, rotator cuff strains, and chronic joint inflammation are the most cited use cases in Wolverine Stack community protocols. BPC-157's pro-angiogenic effect is particularly relevant for poorly vascularised connective tissue, while TB-500 extends repair signals systemically — making the combination especially relevant for multi-site or slow-healing injuries compared to localised single-peptide approaches.

How do I reconstitute and store Bluepeps BPC-157 10mg correctly?

Add 2 ml of bacteriostatic water to the vial for a working concentration of 5 mg/ml (500 mcg per 0.1 ml). Reconstituted BPC-157 should be refrigerated at 2–8 °C and used within 28 days. The lyophilised powder is stable at room temperature for short transit periods; once opened, keep refrigerated and avoid repeated freeze-thaw cycles to preserve peptide integrity.

Can I use an insulin syringe to dose Bluepeps BPC-157, and what needle size is recommended?

Yes — a standard U-100 insulin syringe (29–31 gauge, 0.5 ml) is the practical tool for BPC-157 dosing. At the 5 mg/ml reconstitution ratio, 250 mcg equals 0.05 ml and 500 mcg equals 0.1 ml, both easily measurable on a U-100 barrel. Subcutaneous injection into the abdominal fold or close to the injury site are the two most common delivery approaches in Wolverine Stack protocols. (2) angle_used

Top Seller

Bluepeps

BPC-157 10mg/vial 1 Vial by Bluepeps

Name: BPC-157
Brand: Bluepeps
SKU: PEPT-BPC-BLU-004
Price: 40.00 EUR
Availability: InStock

Bluepeps BPC-157 delivers 10 mg of lyophilised body protection compound per vial — engineered for athletes running the Wolverine Stack, the widely adopted dual-peptide protocol that pairs BPC-157 with TB-500 (Thymosin Beta-4) to accelerate tissue repair on two complementary biological axes. Used together, BPC-157 drives angiogenesis and collagen matrix remodelling at injury sites while TB-500 mobilises actin polymerisation and systemic cell migration, producing a synergistic healing effect that neither peptide achieves alone. Quality is locked in at source: each Bluepeps lot clears reversed-phase HPLC identity confirmation plus a LAL endotoxin screen before release.

€40.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Drives VEGF-mediated angiogenesis at localised injury sites for faster vascular rebuilding
Activates fibroblast proliferation to lay fresh collagen matrix in damaged connective tissue
Mechanistically complements TB-500 in the Wolverine Stack for dual-pathway recovery
10 mg per vial provides enough material for a full 4-week acute healing phase
Lot-specific HPLC and LAL documentation ensures declared peptide content and safety profile
Suitable for subcutaneous or intramuscular delivery adjacent to the injury site
Lyophilised format maintains peptide stability during storage and international shipping

Phase	BPC-157 Dose	TB-500 Dose	Note
Acute (Weeks 1–4)	500 mcg/day	2–2.5 mg twice weekly	Inject BPC-157 close to injury; TB-500 subcutaneous abdomen
Maintenance (Weeks 5–8)	250 mcg/day	2 mg once weekly	Continue collagen remodelling support; taper as injury resolves
Off-cycle	None	None	Allow 4-week washout before reassessing injury status

Key takeaways

Combine BPC-157 with TB-500 for dual-axis injury repair synergy.
Stack BPC-157 locally and TB-500 systemically for sequential healing.
Dose 250–500 mcg daily during the acute Wolverine protocol phase.
Verify lot-specific HPLC and LAL certificates before each Bluepeps vial.
Refrigerate reconstituted vials and use within 28 days of mixing.

What Makes BPC-157 the Cornerstone of the Wolverine Stack

Bluepeps BPC-157 is a synthetic 15-amino-acid peptide — identical in sequence to a fragment of human gastric juice protein — that researchers identify as a primary angiogenic and fibroblast-activating agent within the Wolverine Stack, a dual-peptide healing protocol co-administered alongside TB-500. BPC-157 upregulates VEGF expression and stimulates nitric oxide synthase, increasing local blood vessel formation at damaged tissue. Compared to using BPC-157 in isolation, the Wolverine Stack adds TB-500's systemic actin-binding action, shortening observable recovery windows in published rodent studies by a meaningful margin.

How the BPC-157 + TB-500 Protocol Works

The Wolverine Stack operates through two non-overlapping mechanisms. BPC-157 acts locally: it binds the EGF receptor and activates downstream fibroblast proliferation, laying fresh collagen at the repair site. TB-500 acts systemically: Thymosin Beta-4 sequesters G-actin to promote cell migration across wound margins. Together, BPC-157 and TB-500 create a sequential repair cascade — vascular scaffold first, cellular repopulation second — that is mechanistically superior to either agent alone. Athletes with ligament tears, rotator cuff injuries, and stress fractures represent the injury profiles most frequently referenced in the community for this combination.

Bluepeps Quality Assurance — HPLC and LAL Testing

Bluepeps subjects every production lot to two discrete analytical steps: reversed-phase HPLC confirms peptide identity and purity against a certified reference standard, while a Limulus Amebocyte Lysate (LAL) endotoxin assay verifies that biological contamination remains below USP-defined thresholds. The resulting certificate of analysis is lot-specific, not batch-generic. Each vial contains 10 mg lyophilised BPC-157 — a concentration that provides flexibility for both the low-dose maintenance phase (250 mcg/day) and the higher-dose acute phase (500 mcg/day) common in Wolverine Stack protocols.

Usage

Gather supplies: Bluepeps BPC-157 vial, bacteriostatic water, U-100 insulin syringe (29–31G), alcohol swabs.
Reconstitute by injecting 2 ml bacteriostatic water slowly down the vial wall — do not shake; roll gently to dissolve the lyophilised powder completely.
Identify your injection site: for Wolverine Stack acute-phase dosing, subcutaneous tissue closest to the target injury site is preferred for BPC-157; TB-500 is administered separately in the abdominal fold.
Draw 0.1 ml (500 mcg) for acute phase or 0.05 ml (250 mcg) for maintenance phase using your insulin syringe.
Wipe the injection site with an alcohol swab, allow to dry, then inject subcutaneously or intramuscularly at a 45–90° angle depending on site and body composition.
Store the reconstituted vial in the refrigerator at 2–8 °C, label with the reconstitution date, and discard after 28 days.

Warnings

Contraindications: Not intended for use by individuals under 18. Avoid if pregnant, breastfeeding, or with a personal or family history of hormone-sensitive tumours. BPC-157 has not been approved by any regulatory body for human therapeutic use; all data referenced originates from preclinical research.

Side Effects: Reported events in self-experimenting communities include mild nausea immediately post-injection, transient dizziness, and localised injection-site redness. No peer-reviewed human safety data are available; all effects remain anecdotal at this stage.

Monitoring: Track injection sites for signs of infection (persistent redness, swelling, warmth). If running BPC-157 alongside TB-500 in the Wolverine Stack long-term, periodic blood panels covering inflammatory markers (CRP, ESR) are prudent. Discontinue immediately if systemic allergic reactions occur.

PCT: BPC-157 and TB-500 are non-hormonal peptides and do not suppress the hypothalamic-pituitary-gonadal axis; a conventional PCT cycle is not required after completing this stack.

Frequently asked questions

Why do bodybuilders stack BPC-157 with TB-500 in the Wolverine protocol?: The stack is popular because BPC-157 and TB-500 target injury repair through completely different pathways. BPC-157 stimulates local angiogenesis and fibroblast activity via VEGF upregulation, while TB-500 drives systemic actin polymerisation and cell migration. Combining them addresses both vascular rebuilding and cellular repopulation simultaneously — a dual-axis approach neither peptide can replicate on its own.
What does a typical Wolverine Stack weekly protocol look like?: A common research-based template runs BPC-157 at 250–500 mcg once daily (subcutaneous or intramuscular, site-adjacent), paired with TB-500 at 2–2.5 mg twice weekly for the first four weeks, then dropping to a maintenance dose of 2 mg once weekly. The acute phase targets active injury; the maintenance phase supports ongoing collagen remodelling. Always reconstitute each peptide separately in bacteriostatic water.
Which injury types benefit most from running BPC-157 alongside TB-500?: Ligament and tendon tears, rotator cuff strains, and chronic joint inflammation are the most cited use cases in Wolverine Stack community protocols. BPC-157's pro-angiogenic effect is particularly relevant for poorly vascularised connective tissue, while TB-500 extends repair signals systemically — making the combination especially relevant for multi-site or slow-healing injuries compared to localised single-peptide approaches.
How do I reconstitute and store Bluepeps BPC-157 10mg correctly?: Add 2 ml of bacteriostatic water to the vial for a working concentration of 5 mg/ml (500 mcg per 0.1 ml). Reconstituted BPC-157 should be refrigerated at 2–8 °C and used within 28 days. The lyophilised powder is stable at room temperature for short transit periods; once opened, keep refrigerated and avoid repeated freeze-thaw cycles to preserve peptide integrity.
Can I use an insulin syringe to dose Bluepeps BPC-157, and what needle size is recommended?: Yes — a standard U-100 insulin syringe (29–31 gauge, 0.5 ml) is the practical tool for BPC-157 dosing. At the 5 mg/ml reconstitution ratio, 250 mcg equals 0.05 ml and 500 mcg equals 0.1 ml, both easily measurable on a U-100 barrel. Subcutaneous injection into the abdominal fold or close to the injury site are the two most common delivery approaches in Wolverine Stack protocols. (2) angle_used

Manufacturer

Bluepeps operates with a quality-first laboratory framework built around two mandatory analytical checkpoints for every peptide lot it releases. Incoming raw BPC-157 material is subjected to reversed-phase high-performance liquid chromatography (HPLC) to confirm sequence identity and verify that active peptide content matches the declared 10 mg per vial specification within accepted tolerances. A separate Limulus Amebocyte Lysate (LAL) endotoxin assay then quantifies residual biological contamination, ensuring the final product meets defined safety thresholds before packaging. Lot-specific certificates of analysis — not batch-pooled summaries — are generated for each production run, providing traceability that researchers and athletes running the Wolverine Stack can reference when evaluating product suitability.

Product details

Brand	Bluepeps
Active ingredient	bpc-157
Also known as	Body Protection Compound 157, BPC -157 10mg (1vial), BPC-157, Bluepeps Body Protection Compound 157
Strength	10 mg
Form	Vial
Pack size	1 piece
Item number	PEPT-BPC-BLU-004

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Pharma Grade

BPC -157 10mg 10mg/10ml 1 Vial by Swiss Pharma

BPC-157 is a stable, synthetic 15-amino-acid peptide originally isolated from gastric juice, formulated at 10 mg per 10 ml by Swiss Pharma — notable for its emerging role in GH-axis receptor sensitisation and vascular support during lipolytic cycles. At 1 mg/ml, precise low-volume draws align with the micro-dosing schedules used in structured fat-loss research, where BPC-157's influence on GH receptor expression may potentiate adipocyte fatty acid release. Each production lot is cleared through two independent, lot-specific laboratory procedures — reversed-phase HPLC for active peptide quantification and LAL endotoxin assay for injectable-grade safety — before dispatch.

€55.00

Lab Tested

BPC-157 5mg/vial 1 Vial by Bio-Peptide

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide extensively studied for musculoskeletal repair, giving researchers the option of localised peri-articular injection or systemic subcutaneous delivery for broader connective-tissue recovery. Each vial from Bio-Peptide supplies 5 mg of lyophilized BPC-157, a research-grade concentration well-suited to tendon, ligament, and joint rehabilitation protocols. Independent HPLC purity analysis and LAL endotoxin testing are applied to every batch, with production carried out under current Good Manufacturing Practice (cGMP) conditions.

€34.00

HPLC Verified

BPC-157 20mg/vial 1 Vial by Knoll Pharmaceuticals

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide sourced from a protective protein in human gastric juice, presented by Knoll Pharmaceuticals as a lyophilised powder at 20 mg per vial — the highest concentration available in this single-vial format. Studies show it supports gastrointestinal mucosal integrity, accelerates gut-lining regeneration, and modulates nitric-oxide pathways governing intestinal blood flow. Every batch undergoes HPLC purity verification and LAL endotoxin screening prior to release under GMP production conditions.

€30.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00